NIH-funded research R01 grant

Understanding how ribonucleotides affect telomeres and cancer.

Official title: Ribonucleotide Processing in Telomere Maintenance and Integrity

Funded at University of Kansas Medical Center · NIH-11072066 · Data updated 2026-11-12

This study is looking at how certain building blocks in our cells, called ribonucleotides, help keep the protective caps on our chromosomes, known as telomeres, healthy, and how this might be linked to cancer, so we can find better ways to treat the disease.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Kansas Medical Center
NIH-funded
Lab location1 site (Kansas City, United States)
Project startMay 1, 2024
Project endApril 30, 2029
Funding year2025
Award (this year)$477,252
NIH project number5R01CA284633-02
Project IDNIH-11072066 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals with a history of cancer or those at high risk for developing cancer due to genetic factors.

Less likely to help

Patients with non-cancerous conditions or those without any known genetic predisposition to cancer may not benefit from this research.

What this research studies

This research investigates the role of ribonucleotides in telomere maintenance and their implications for cancer development. Telomeres, which protect the ends of chromosomes, can become damaged and lead to cell aging or death when they shorten. The study aims to explore how the enzyme telomerase, which helps maintain telomere length, incorporates ribonucleotides into telomeres and how this may contribute to genomic instability and cancer. By examining these processes, the research seeks to uncover new insights into cancer biology and potential therapeutic targets.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for preventing or treating cancers associated with telomere dysfunction.

How similar studies have gone: While the specific focus on ribonucleotides in telomeres is relatively novel, previous research has successfully explored telomere biology and its implications for cancer.

Where this research is happening

  • University of Kansas Medical Center
    Kansas City, United States
    Active

Researchers

  • Principal investigator: Freudenthal, Bret D — University of Kansas Medical Center
  • Study coordinator: Freudenthal, Bret D

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.